Miyashita Naoyuki | Division Of Respiratory Diseases Department Of Internal Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Seroprevalence of Antibodies to Chlamydia spp.in Human Immunodeficiency Virus-Infected Subjects in Japan
Continuous Isolation and Characterization of Chlamydia pneumoniae from a Patient with Diffuse Panbronchiolitis
マイコプラズマにおけるブレイクポイントの考え方
Macrolide-resistant Mycoplasma pneumoniae in patients with community-acquired pneumonia
Influence of gatifloxacin, a new quinolone antibacterial, on pharmacokinetics of theophylline
Pulmonary Alveolar Proteinosis with Bilateral Ground-glass Opacities Localized in Subpleural Areas
Evaluation of the diagnostic usefulness of real-time PCR for detection of Chlamydophila pneumoniae in acute respiratory infections
Pulmonary Mycobacterium intracellulare disease with a solitary pulmonary nodule detected at the onset of pneumothorax
Lung Adenocarcinoma Required the Differentiation from Wegener Granulomatosis
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates
Infectious bulla of the lung caused by Mycobacterium intracellulare
Hermansky-Pudlak Syndrome with Interstitial Pneumonia without Mutation of HSP1 Gene
Multifocal Micronodular Pneumocyte Hyperplasia in a Man with Tuberous Sclerosis
Chronic Necrotizing Pulmonary Aspergillosis Complicated by a Cavitary Lesion Caused by Pulmonary Mycobacterium-avium Complex Disease
Pulmonary Mycobacterium Avium Disease with a Solitary Pulmonary Nodule Requiring Differentiation from Recurrence of Pulmonary Adenocarcinoma
Thoracic actinomycosis with mainly pleural involvement
Effect of pazufloxacin mesilate on the serum concentration of theophylline
The 7.5-kb common plasmid is unrelated to the drug susceptiility of Chlamydia trachomatis
Serum KL-6 as a Possible Marker for Amiodarone-induced Pulmonary Toxicity
Clinical evaluation of QuantiFERON TB-2G test in patients with healed pulmonary tuberculosis
An asymptomatic case of pulmonary cryptococcosis with endobronchial polypoid lesions and bilateral infiltrative shadow
Clinical features of immunocompromised and nonimmunocompromised patients with pulmonary tuberculosis
In Vitro Susceptibility of 7.5-kb Common Plasmid-Free Chlamydia trachomatis Strains
Self-limiting Pneumonia Due to Chlamydia pneumoniae
In Vitro and In Vivo Activities of Sparfloxacin and Reference Drug Against Chlamydia pneumoniae
Recurrent Pneumonia due to Persistent Chiamydia Pneumoniae Infection
Solitary Pulmonary Nodule Due to Mycobacterium kansasii
Problem of Chlamydia pneumoniae Serology Today
In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species
Pulmonary Mycobacterium massiliense Disease with Septicemia during Immunosuppressive Treatment
Japanese guidelines for the management of community-acquired pneumonia : is it possible to distinguish between mycoplasmal pneumonia and bacterial pneumonia?
Clinical Evaluation of the T-SPOT.TB Test for Patients with Indeterminate Results on the QuantiFERON TB-2G Test
Usefulness of Tuberculin Skin Test and Three Interferon-Gamma Release Assays for the Differential Diagnosis of Pulmonary Tuberculosis

もっと見る

スポンサーリンク